Suzuken Co Ltd
TSE:9987
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
JP |
Suzuken Co Ltd
TSE:9987
|
361.5B JPY | 13.1 | ||
US |
Mckesson Corp
NYSE:MCK
|
70.3B USD | 23.5 | ||
US |
Cencora Inc
NYSE:COR
|
48.5B USD | 26 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
27.3B USD | 42.7 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.8B USD | 23.5 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
IT |
Amplifon SpA
MIL:AMP
|
7.6B EUR | 49.2 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
62.6B HKD | 6.5 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
54B CNY | 20 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
48.6B CNY | 10.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.